Anne Mills
10PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Sep 08, 2021
Targeting immune checkpoints in gynecologic cancer: updates & perspectives for pathologists.Anne M Mills, Tim N Bullock, Kari L Ring
|Oct 04, 2020
MHC class I loss in endometrial carcinoma: a potential resistance mechanism to immune checkpoint inhibition.Lisa A Friedman, Timothy N Bullock, Emily A Sloan
|Mar 07, 2020
Looking past PD-L1: expression of immune checkpoint TIM-3 and its ligand galectin-9 in cervical and vulvar squamous neoplasia.Jacob Curley, Mark R Conaway, Zachary Chinn
|Mar 31, 2019
TIM-3 in endometrial carcinomas: an immunotherapeutic target expressed by mismatch repair-deficient and intact cancers.Margaret Moore, Kari L Ring, Anne M Mills
|Mar 17, 2019
Uterine and vaginal sarcomas resembling fibrosarcoma: a clinicopathological and molecular analysis of 13 cases showing common NTRK-rearrangements and the description of a COL1A1-PDGFB fusion novel to uterine neoplasms.Sabrina Croce, Isabelle Hostein, Teri A Longacre
|Aug 02, 2018
PD-L1 and IDO expression in cervical and vulvar invasive and intraepithelial squamous neoplasias: implications for combination immunotherapy.Zachary Chinn, Mark H Stoler, Anne M Mills
Pageof 2
